Rett syndrome in Australia: a review of the epidemiology.
暂无分享,去创建一个
Carol Bower | J. Christodoulou | H. Leonard | D. Ravine | N. de Klerk | C. Ellaway | C. Bower | John Christodoulou | Crystal L Laurvick | Nicholas de Klerk | Helen Leonard | Carolyn Ellaway | David Ravine | Sarah Williamson | S. Williamson | C. Laurvick
[1] B. Hagberg. Rett's Syndrome: Prevalence and Impact on Progressive Severe Mental Retardation in Girls , 1985, Acta paediatrica Scandinavica.
[2] T. Talvik,et al. Rett syndrome in Estonia: prevalence of the classical phenotype , 1995, Acta paediatrica.
[3] J. Seidman,et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling , 2005, Journal of Medical Genetics.
[4] J. Stephenson,et al. A study of the natural history of Rett syndrome in 23 girls. , 1986, American journal of medical genetics. Supplement.
[5] H. Zoghbi,et al. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. , 2000, American journal of medical genetics.
[6] M. Miyao,et al. Multi-institutional survey of the rett syndrome in Japans , 1990, Brain and Development.
[7] D. Cooper,et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. , 2000, Human molecular genetics.
[8] D. English,et al. The prevalence and incidence of Rett syndrome in Australia. , 1997, European child & adolescent psychiatry.
[9] A. Clarke,et al. Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls , 2005, European Journal of Human Genetics.
[10] B. Hagberg,et al. Rett syndrome: Epidemiology and nosology — progress in knowledge 1986 — A conference communication , 1987, Brain and Development.
[11] J. Christodoulou,et al. p.R270X MECP2 mutation and mortality in Rett syndrome , 2005, European Journal of Human Genetics.
[12] E. Hoffman,et al. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. , 2002, Mental retardation and developmental disabilities research reviews.
[13] T. Matsuishi,et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? , 2003, Journal of medical genetics.
[14] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[15] L. Burd,et al. Prevalence study of Rett syndrome in North Dakota children. , 1991, American journal of medical genetics.
[16] H. Zoghbi,et al. Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome , 2005, Journal of Medical Genetics.
[17] C. Mellis,et al. Evaluation of a national surveillance unit , 1999, Archives of disease in childhood.
[18] F. Hanefeld,et al. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[19] F. Hanefeld,et al. Molecular and neurobiology aspects of Rett syndrome. , 1995, Neuropediatrics.
[20] P. Huppke,et al. The spectrum of phenotypes in females with Rett Syndrome , 2003, Brain and Development.
[21] B. Hagberg. Clinical Delineation of Rett Syndrome Variants , 1995, Neuropediatrics.
[22] E. Ballestar,et al. Methyl-CpG-binding proteins. Targeting specific gene repression. , 2001, European journal of biochemistry.
[23] O. Skjeldal,et al. Rett syndrome: geographic variation in prevalence in Norway , 1997, Brain and Development.
[24] Jean Aicardi,et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases , 1983, Annals of neurology.
[25] I. György,et al. [Rett's syndrome]. , 1987, Orvosi hetilap.
[26] J. Gécz,et al. Rett syndrome: clinical review and genetic update , 2005, Journal of Medical Genetics.
[27] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[28] L. Samuelsson,et al. Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. , 2003, Genetic testing.
[29] A. Renieri,et al. Rett syndrome: the complex nature of a monogenic disease , 2003, Journal of Molecular Medicine.
[30] D. Glaze,et al. Epidemiology of Rett syndrome: a population-based registry. , 1993, Pediatrics.
[31] N. Laing,et al. Effects of MECP2 mutation type, location and X‐inactivation in modulating Rett syndrome phenotype , 2003, American journal of medical genetics. Part A.
[32] P. Huppke,et al. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. , 2000, Human molecular genetics.
[33] E. Dodd. Classification of Sizes or Measures by Frequency Functions , 1931 .
[34] M. Msall,et al. Describing the phenotype in Rett syndrome using a population database , 2003, Archives of disease in childhood.
[35] J Christodoulou,et al. Refining the phenotype of common mutations in Rett syndrome , 2004, Journal of Medical Genetics.
[36] J. Stephenson,et al. Rett's syndrome in the west of Scotland. , 1985, British medical journal.